Layout 4 - Aristea

www.aristea.com/acscrossroads
BAVENO, ITALY - OCTOBER 10 /11, 2 014
V INTERNATIONAL ACS CROSSROADS
PROGRAM
Under the patronage of
Sezione Regionale Piemonte – Valle d’Aosta
DAY 1 - FRIDAY, OCTOBER 10, 2014
14.30 Welcome and Introduction
SESSION I
UPDATE ON ORAL ANTIPLATELET THERAPIES
Chairmen: G. De Luca, F. Piscione
15.30 Resistance to aspirin and ADP-antagonists:
Mechanism, prevalence and
clinical relevance - M. Cattaneo
15.40 Update on pharmacological gastroprotection:
when and how - G. Belli
15.50 Switching from clopidogrel to new ADP
antagonist: When and how - G. Parodi
16.00 ACCOAST Study: is an upstream strategy
still necessary? - J.P. Collet
16.10 Ticagrelor and its pleiotropic effects - D. Ardissino
16.20 Optimal duration of DAPT - G. De Luca
16.30 MODERATED DISCUSSION
Discussants: M. Ferlini, G. Galasso, A. Mafrici,
M. Napodano, U. Zeymer
SESSION II
TRIPLE ORAL THERAPY IN ACS:
WHAT HAS BEEN DONE AND WHAT’S GOING ON!
Chairmen: J.P. Collet, D. Dudek
16.45 Rationale for Triple therapy in ACS - G. Galasso
16.55 PAR-1 Antagonists - F. Varbella
17.05 Factor Xa Inhibitors - A. Mafrici
17.15 MODERATED DISCUSSION
Discussants: G. Galasso, G. Musumeci, G. Parodi
F. Piscione, G.G. Secco
SESSION III
FLASH DEBATE: OPTIMAL ANTITHROMBOTIC
THERAPY IN STEMI WITH NEW ORAL
ADP ANTAGONISTS
Chairmen: K. Huber, G. Parodi
17.30 Gp IIb-IIIa inhibitors - G. De Luca
17.40 Bivalirudin - D. Dudek
17.55 Cangrelor: a new player? - A. Rognoni
18.05 MODERATED DISCUSSION
Discussants: A. Lupi, M. Romano, G. Tarantini,
F. Varbella, U. Zeymer
SESSION IV
YOUNG INTERVENTIONALIST COMPETITION:
MY WORST COMPLICATION IN THE CATH LAB!
Chairmen: D. Antonucci, D. Dudek
18.20 Case 1 - To be selected
18.35 Case 2 - To be selected
18.50 Case 3 - To be selected
19.05 Case 4 - To be selected
Discussants: G. Belli, M. D’Amico, P. Gaetano,
M. Romano, P. Silva, H. Thiele
19.20 LECTURE
New ADP antagonists and Gp IIb-IIIa inhibitors
in ACS: when and how to use - J.P. Collet
DAY 2 - SATURDAY, OCTOBER 11, 2014
SESSION V
ANTIPLATELET THERAPY AND SURGERY
Chairmen: P. Marino, L. Oltrona-Visconti
SESSION VI
FLASH DEBATE: THROMBECTOMY IN 2014
Chairmen: K. Huber, H. Suryapranata
08.30 Need of surgery under dual antiplatelet therapy:
Prevalence and Outcome - S. De Servi
09.25 No proof for routine thrombectomy - S. James
08.40 Current status on Bridge therapy - S. Savonitto
08.50 The Italian consensus document - G. Musumeci
09.00 SAS Registry - R. Rossini
09.10 MODERATED DISCUSSION
Discussants: M. Commodo, M. D’Urbano, F. Grassi,
E. Passamonti, A. Rognoni, C. Sponzilli,
09.35 No power no party: go for
rheolytic thrombectomy - D. Antoniucci
09.45 MODERATED DISCUSSION
Discussants: R. Garbo, E. Kedhi, E. Meliga,
R. Moreno, G.G. Secco, A. Silvestro
SESSION VII
ANTITHROMBOTIC MANAGEMENT OF ACS
PATIENTS WITH ATRIAL FIBRILLATION
Chairmen: S. James, R. Moreno
10.00 Prevalence and management of AF in ACS - F. Saia
10.10 Triple therapy: The WOEST study - E. Kedhi
10.20 New Oral Anticoagulants and new
ADP-antagonists: how do they fit? - K. Huber
10.30 New stent strategies - E. Meliga
10.40 MODERATED DISCUSSION
Discussants: G. Boccuzzi, D. Capodanno,
P. Colombo, M. Ferlini,
P. Gaetano, H. Thiele
11.00 Coffee break
SESSION VIII
TAVI: THE NEW HORIZONS
Chairmen: S. Berti, G. Pedrazzini
11.30 Balloon expandable valves:
what’s new - G. Napodano
11.40 TAVI for aortic regurgitation:
current data and future indications - L. Testa
11.50 New valves - F. De Marco
12.00 DISCUSSION
Discussants: G. Bruschi, P. Colombo,
M. Commodo, C. Moretti,
M. Napodano, F. Saia, M. Tespili
DAY 2 - SATURDAY, OCTOBER 11, 2014
SESSION IX
YOUNG INTERVENTIONALIST COMPETITION:
MY WORST COMPLICATION IN THE CATH LAB!
Chairmen: R. Garbo, M. Tespili
12.20 Case 1 - To be selected
12.30 Case 2 - To be selected
POSTER SESSION
SESSION X
BEYOND THROMBOSIS AND REVASCULARIZATION.
NEW DRUGS IN THE ARENA
Chairmen: G. De Luca, G. Parodi
SESSION XI
DES IN ACS: 2014 UPDATE
Chairmen: A.S. Bongo, D. Antoniucci
15.20 Dual-therapy stent - H. Suryapranata
15.30 Self-expanding stent - D. Capodanno
16.30 IVUS for optimal stenting:
routine or selective use? - A. Lupi
16.40 MODERATED DISCUSSION
Discussants: L. Golino, E. Piccaluga,
A. Rognoni, G. Tarantini
12.40 Case 3 - To be selected
14.30 Ranolazine: rationale, current data
and ongoing trials - F. Pelliccia
15.40 Bioabsorbable polymer
with everolimus - R. Moreno
12.50 Case 4 - To be selected
14.40 HDL and CETP inhibitors - L. Calabresi
15.50 Hybrid DES - G.G. Secco
17.00 LECTURE
miRNAs and cardiovascular disease:
state-of-the-art - L. Elia
Presenter: G. De Luca
14.50 Erectile dysfunction: prevalence,
prognostic implications and
therapeutic approach - F. Lanfranco
16.00 CoCr SES with hydrophilic coating
and Bioabsorbable polymer - G.B. Danzi
17.30 CEREMONY
Winners of Young Investigator competitions
16.10 Polymer-free SES and stainless steel SES
with Bioabsorbable polymer - G. De Luca
18.00 Conclusions
Discussants: G.B. Danzi, C. Godino, A. Lupi,
E. Piccaluga, A. Silvestro, F. Varbella
13.00 Mechanical support for cardiogenic shock:
from the present to the future - H. Thiele
13.30 Lunch
15.00 MODERATED DISCUSSION
Discussants: G. Galasso, A. Lupi, G.G. Secco
16.20 BVS: when and how - G. Boccuzzi
INTERNATIONAL FACULTY
NATIONAL FACULTY
J.P. Collet
Paris, France
D. Dudek
Krakow, Poland
K. Huber
Vienna, Austria
S. James
Upssala, Sweden
E. Kedhi
Zwolle, The Netherlands
R. Moreno
M. Noc
G. Pedrazzini
H. Suryapranata
H. Thiele
Madrid, Spain
Ljiubiana, Slovenia
Lugano, Switzerland
Nijmegen, The Netherlands
Leipzig, Germany
F. Airoldi
D. Antoniucci
D. Ardissino
Milan
Florence
Parma
G. Belli
Bergamo
S. Berti
Massa
G. Boccuzzi
Turin
D. Capodanno
Catania
S. De Servi
Pavia
Florence
S. Savonitto
E. Passamonti
Cremona
G.G. Secco
Lecco
M. D’Urbano
M. Cattaneo
Milan
L. Elia
Milan
A. Lupi
P. Colombo
Milan
M. Ferlini
Pavia
A. Mafrici
Milan
Novara
P. Gaetano
Ciriè
P. Marino
Novara
Milan
G. Galasso
Naples
E. Meliga
Turin
P. Presbitero
Turin
A. Rognoni
Novara
Bergamo
M. Romano
Mantova
L. Testa
Milan
R. Rossini
Bergamo
F. Varbella
Turin
L. Bolognese
Arezzo
M. D’Amico
A.S. Bongo
Novara
M. De Benedictis
A.W.J. van’t Hof
Zwolle, The Netherlands
G. Bruschi
Milan
G. De Luca
U. Zeymer
Ludwigshafen, Germany
L. Calabresi
Milan
F. De Marco
Torino
Turin
Novara
Milan
R. Garbo
Turin
C. Moretti
C. Godino
Milan
G. Musumeci
L. Golino
F. Grassi
Gravedona
Novara
Mantova
G. Parodi
Milan
G.B. Danzi
C. Lettieri
Turin
M. Carlino
M. Commodo
Magenta
F. Lanfranco
Novara
M. Napodano
L. Oltrona-Visconti
Padua
Pavi
Novara
F. Pelliccia
Rome
P. Silva
E. Piccaluga
Milan
A. Silvestro
Seriate
Salerno
C. Sponzilli
Milano
Milan
G. Tarantini
Padua
F. Piscione
F. Saia
Bologna
M. Tespili
Milan
Seriate
GENERAL INFORMATION
COURSE DIRECTORS
Giuseppe De Luca (Italy)
Harry Suryapranata (The Netherlands)
CONGRESS VENUE
Grand Hotel Dino
Corso Garibaldi, 20 • 28831 Baveno • Italy
SCIENTIFIC COMMITTEE
Giuseppe De Luca (Italy)
Harry Suryapranata (The Netherlands)
David Antoniucci (Italy)
Dariusz Dudek (Poland)
Guido Parodi (Italy)
C.M.E. PROVIDER
SCIENTIFIC SECRETARY
Monica Verdoia (Italy)
Alon Schaffer (Italy)
Ettore Cassetti (Italy)
Lucia Barbieri (Italy)
Gabriella Di Giovine (Italy)
Matteo Nardin (Italy)
Via Roma, 10 • 16121 Genova • Italy
Tel. (+39) 010 553591 • Fax (+39) 010 5535970
E-mail genova@aristea.com • Web www.aristea.com
C.M.E.
Aristea Education (Provider N° 500) will include the congress
in the Educational Plan 2014 granting 10 C.M.E. credits.
The congress will be suited for the following specializations
within the medical profession: Surgeons (emergency ricovery,
heart surgeons, cardiologists, diabetologists, hematologists,
geriatricians, general practitioners, internists, psychiatrists,
renal specialists), Nurses and Radiologic Technologists.
In order to obtain C.M.E. credits, participants must attend
the whole conference and submit the completed evaluation
questionnaire and C.M.E. Verification Form.
The certificate of attendance with the number of C.M.E.
credits assigned can be downloaded after 60 days from
the date of the congress directly through the website
www.aristea.com/ecm
ON-LINE REGISTRATION
The registration is free of charge but mandatory. For on-line
registration please visit the website of the Congress:
www.aristea.com/acscrossroads
ORGANIZING SECRETARIAT
Via Roma, 10 • 16121 Genova • Italy
Tel. (+39) 010 553591 • Fax (+39) 010 5535970
E-mail acscrossroads@aristea.com • Web www.aristea.com
WEB SITE
www.aristea.com/acscrossroads

Download Report